A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Status:
Completed
Trial end date:
2015-03-24
Target enrollment:
Participant gender:
Summary
To describe liver enzyme elevations in patients who are coinfected with HIV and either
Hepatitis C (HCV) and/or Hepatitis B (HBV) receiving maraviroc or placebo in combination with
their current suppressive anti-HIV drug therapy.